[Clinical studies on serum leucyl glycyl glycine hydrolyzing enzyme in cancer. II].
D000328:Adult; D000368:Aged; D000596:Amino Acids / Q000494:pharmacology*; D000626:Aminopeptidases / Q000097:blood; D005260:Female; D005998:Glycine / Q000494:pharmacology; D006801:Humans; D007930:Leucine / Q000494:pharmacology; D007931:Leucyl Aminopeptidase / Q000097:blood; D008113:Liver Neoplasms / Q000201:enzymology; D008297:Male; D009369:Neoplasms / Q000201:enzymology*; D010447:Peptide Hydrolases / Q000097:blood*; D010455:Peptides / Q000494:pharmacology*; D011247:Pregnancy; D011480:Protease Inhibitors; D013274:Stomach Neoplasms / Q000201:enzymology
D000596:Amino Acids; D010455:Peptides; D011480:Protease Inhibitors; D010447:Peptide Hydrolases; D000626:Aminopeptidases; D007931:Leucyl Aminopeptidase; D007930:Leucine; D005998:Glycine